Adverse pregnancy outcomes among HIV-positive pregnant women treated with efavirenz-containing antiretroviral drugs: a retrospective cohort study in the Cape Flats
dc.contributor.advisor | Mugabo, Pierre | |
dc.contributor.author | Mohammednur, Mohammedmekin Mohammedseid | |
dc.date.accessioned | 2018-08-02T12:27:41Z | |
dc.date.accessioned | 2024-05-15T07:16:51Z | |
dc.date.available | 2018-08-02T12:27:41Z | |
dc.date.available | 2024-05-15T07:16:51Z | |
dc.date.issued | 2017 | |
dc.description | Doctor Pharmaceuticae - Dpharm | en_US |
dc.description.abstract | The use of efavirenz (EFV) in the first trimester of pregnancy remains controversial. In South Africa, the use of EFV-containing antiretroviral therapy (ART) as part of a Fixed Dose Combination (FDC) during the first trimester of pregnancy started in April, 2013. Literature to date has reported conflicting outcomes following the use of EFV-containing ART during the first trimester of pregnancy. The objectives of the study were to determine the prevalence of adverse pregnancy outcomes among HIV-positive pregnant women treated with EFV-containing ART and compare these results with those of pregnant women treated with NVP-containing ART and HIV-negative pregnant women in resource-limited settings. In addition, the study also aimed to determine the effect of the time of initiation of ART on the prevalence of adverse pregnancy outcomes. | en_US |
dc.identifier.uri | https://hdl.handle.net/10566/15058 | |
dc.language.iso | en | en_US |
dc.publisher | University of the Western Cape | en_US |
dc.rights.holder | University of the Western Cape | en_US |
dc.subject | Adverse pregnancy outcomes | en_US |
dc.subject | Antiretroviral drug | en_US |
dc.subject | Birth defect | en_US |
dc.subject | Efavirenz | en_US |
dc.subject | First trimester | en_US |
dc.subject | HIV | en_US |
dc.subject | Low birth weight | en_US |
dc.subject | Nevirapine | en_US |
dc.subject | Pregnant women | en_US |
dc.subject | Preterm delivery | en_US |
dc.title | Adverse pregnancy outcomes among HIV-positive pregnant women treated with efavirenz-containing antiretroviral drugs: a retrospective cohort study in the Cape Flats | en_US |
dc.type | Thesis | en_US |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- Mohammednur_DPHARM_NSC_2017.pdf
- Size:
- 1.74 MB
- Format:
- Adobe Portable Document Format